Sign In
Buy ILMN
$168.06
-2.87 (-1.68%)
At Close: Jun 04, 2026
7 Stocks Gearing Up for a Major Breakout
12:17pm, Friday, 31'st Mar 2023
The entire stock market is gearing up for a major breakout as investors are becoming convinced that the banking sector has stabilized and that the Federal Reserve is, at the very least, almost done hi
Illumina (ILMN) to Enable Tertiary Analysis With New Launch
01:46pm, Wednesday, 29'th Mar 2023
Illumina's (ILMN) Connected Software is an end-to-end software system that standardizes analysis tools and connects data across the genomics workflow.
Carl Icahn wants to bring back Illumina's ex-CEO 'immediately' as proxy fight intensifies
10:24am, Wednesday, 29'th Mar 2023
Icahn said Illumina should bring back former CEO Jay Flatley, saying current management is making the mistake of holding onto the $7.1 billion Grail deal.
Carl Icahn tells WSJ he wants old CEO back at Illumina
08:08am, Wednesday, 29'th Mar 2023
Illumina Inc. ILMN activist shareholder and billionaire Carl Icahn told The Wall Street Journal he'd like to see the return of ex-CEO Jay Flatley to replace the gene sequencing device maker's current
Carl Icahn Wants to Bring Illumina's Old CEO Back
07:32am, Wednesday, 29'th Mar 2023
The billionaire activist, who has launched a proxy battle at Illumina, wants change at the management level too, and he has a candidate in mind for the top spot: former CEO Jay Flatley.
Illumina Hits Back at Carl Icahn's Grail Deal Claims and His Board Nominations
10:45pm, Tuesday, 28'th Mar 2023
Icahn, who owns a 1.4% stake in Illumina, began his latest proxy battle on March 13, criticizing management for pursuing the 2021 Grail deal amidst regulatory scrutiny.
Illumina: What Is Up With The Genes?
09:54am, Monday, 27'th Mar 2023
Illumina is still facing issues around its GRAIL acquisition. The company has seen continued uncertainty and has incurred a lot of losses with the GRAIL acquisition while the core business was perform
Carl Icahn claims Illumina directors got extra insurance to close 'disastrous' $7.1 billion Grail deal
12:20pm, Friday, 24'th Mar 2023
Carl Icahn claims Illumina directors demanded extra personal liability insurance before the biotech company signed off on a $7.1 billion acquisition of Grail
Illumina shares attractive as conclusion to Grail saga draws closer, broker says
03:01pm, Monday, 20'th Mar 2023
Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have reiterated their ‘Buy' rating for Illumina Inc (NASDAQ:ILMN) following recent activism efforts against the biotechnology company led by veteran ac
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
07:18pm, Saturday, 18'th Mar 2023
Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our d
Icahn proposes three candidates for Illumina's board — Here's what could be next in the battle
08:39am, Saturday, 18'th Mar 2023
A fight has broken out between veteran activist Carl Icahn and biotech company Illumina as the investor nominates three candidates to the board.
Illumina Should Heed Icahn, Give Up on Holy Grail
12:04pm, Friday, 17'th Mar 2023
Management should seek a settlement with the activist that paves the way for a speedier Grail exit
Carl Icahn Responds to Illumina in Open Letter
06:04pm, Thursday, 16'th Mar 2023
Sunny Isles Beach, Florida, March 15, 2023 — Today, Carl C. Icahn released the following open letter to the shareholders of Illumina, Inc. ( ILMN , Financial), responding to the obfuscations contain
Illumina (ILMN) Unveils Complete Long Reads Technology
02:31pm, Wednesday, 15'th Mar 2023
Illumina's (ILMN) Complete Long Read Prep combines Illumina sequencing by synthesis chemistry with DRAGEN secondary analysis to provide WGS with more accuracy.
Icahn Reacts Audaciously To Illumina's Audacity
09:00am, Wednesday, 15'th Mar 2023
Carl Icahn wants three board seats at Illumina after it overpaid for Grail and took on too much regulatory risk. The $3.9 billion impairment charge Illumina took in the fourth quarter makes clear just
